Evidence map›Paper›PMID 42899438›Full record

ArticleJournal of computational chemistry2026

Improved GAFF Force Field for Fused Ring Non-Fullerene Acceptors With 1,1-Dicyanomethylene-3-Indanone Based End Groups.

Konstantinos Kordos, Dimitrios G Papageorgiou

Abstract read
In one paragraph

Article in Journal of computational chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Konstantinos KordosDepartment of Materials Science and Engineering, University of Ioannina, Greece.ORCID https://orcid.org/0000-0001-8134-8145
Dimitrios G PapageorgiouDepartment of Materials Science and Engineering, University of Ioannina, Greece.ORCID https://orcid.org/0009-0009-6675-3105

Funding

Horizon 2020 Framework Programme 953187National Recovery and Resilience Plan Greece 2.0 TAEDR-0537347
6 · The paper itself

Abstract

The introduction of non-fullerene acceptors (NFAs) in bulk heterojunction organic solar cells has advanced their power conversion efficiencies beyond 20%. NFAs consisting of a fused ring electron-donating core, capped with electron-withdrawing end groups, are being intensely investigated both experimentally and computationally, since they demonstrate superior performance. 1,1-dicyanomethylene-3-indanone (IC) is a widely used end group due to its strong electron-withdrawing ability and ease of chemical modification. The functionality of this end group can be further enhanced by employing two common strategies. Halogenation, that adjusts energy levels, and addition of π-extensions that red-shifts optical absorption. In the present work we improve the General Amber Force Field to model fused ring NFAs with a thiophene unit at the edge of the core. To this end, 10 different NFA structures that incorporate the IC end group along with its halogenated and π-extended variants are employed. They are classified into three popular families according to their structural characteristics. Using ab initio computations, the dihedral angles between the fused ring core and the end group are reparametrized, while partial atomic charges are derived using the standard RESP procedure, thus creating complete force field models. Using experimentally resolved crystal structures available in the literature we validate the new parameterization and demonstrate its suitability for modeling a variety of fused ring NFAs.

Indexed as

dicyanomethylene indanone end groupsgeneral Amber force fieldnon‐fullerene acceptorsorganic solar cells

Identifiers

PMID42899438
PMCPMC13681342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.